Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial (nct03687905)

HIGHLIGHTS

• who: Fatma Sayed Gheet from the , have published the paper: Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial (NCT03687905), in the Journal: (JOURNAL) of 05,/09/2018
• what: This study assessed the efficacy and side effects of in children with proliferative (LN). This study demonstrated that 54% of patients had LN class III, 43% had LN class IV, and 3% had LN classes IV-V. This study showed a significant reduction in serum triglycerides, cholesterol, 24-h proteinuria, and Antids-DNA levels in HCQ group after 12 months of treatment. This study . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.